Filing Flows › Vertex Pharmaceuticals (VRTX) › Who owns the stock
Who owns Vertex Pharmaceuticals (VRTX) stock
1,705 funds reported Vertex Pharmaceuticals (VRTX) shares in their latest 13F filings, worth $125.8B in all. The largest holder is Capital World Investors ($13.0B). Last quarter 804 funds added to their stakes and 661 cut them. Members of Congress and other officials disclosed 3 trades (1 buys, 2 sales).
Largest holders (13F)
| Fund | Shares | Value | Change | Quarter |
|---|---|---|---|---|
| Capital World Investors | 26,115,014 | $13.0B | increase | 2026-06-30 |
| BlackRock | 24,109,373 | $12.0B | increase | 2026-06-30 |
| Vanguard Group | 24,105,823 | $10.9B | decrease | 2025-12-31 |
| Capital Research Global Investors | 19,490,637 | $9.7B | decrease | 2026-06-30 |
| Vanguard Capital Management LLC | 16,580,713 | $8.2B | increase | 2026-06-30 |
| State Street | 11,871,459 | $5.9B | increase | 2026-06-30 |
| Invesco | 8,043,052 | $4.0B | increase | 2026-06-30 |
| Geode Capital Management, LLC | 6,017,848 | $3.0B | decrease | 2026-06-30 |
| Vanguard Portfolio Management LLC | 4,878,987 | $2.4B | decrease | 2026-06-30 |
| Capital International Investors | 4,695,144 | $2.3B | decrease | 2026-06-30 |
| Loomis Sayles & Co L P | 3,920,953 | $1.9B | decrease | 2026-06-30 |
| Franklin Resources | 3,347,253 | $1.7B | increase | 2026-06-30 |
| Wellington Management Group LLP | 3,247,658 | $1.6B | increase | 2026-06-30 |
| Morgan Stanley | 3,242,139 | $1.6B | increase | 2026-06-30 |
| UBS AM, a distinct business unit of UBS Asset Management Americas LLC | 3,086,683 | $1.5B | increase | 2026-06-30 |
Trades by Congress and other officials
| Date | Who | Trade | Amount |
|---|---|---|---|
| 2026-08-26 | David J. Taylor | sale | $1K–$15K |
| 2026-03-27 | Alan Armstrong | purchase | $1K–$15K |
| 2026-01-29 | David J. Taylor | sale | $1K–$15K |
Vertex Pharmaceuticals' latest quarter
Vertex Pharmaceuticals, Q3 2026: revenue $3.4B (+12% year over year), operating margin 20.7%, net earnings $654M, operating cash flow $643M. The chart follows the revenue to costs, profit and cash.
Questions
Who owns the most VRTX stock?
By the latest 13F filings: Capital World Investors ($13.0B); BlackRock ($12.0B); Vanguard Group ($10.9B); Capital Research Global Investors ($9.7B); Vanguard Capital Management LLC ($8.2B).
Has Congress traded VRTX stock?
Officials disclosed 3 trades on file: 1 buys and 2 sales. The latest: David J. Taylor, sale on 2026-08-26.
What is the short interest in VRTX?
4,263,331 shares were sold short at the 2026-10-15 settlement, -5.33% of the float.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.